Country - Germany
Summary - Oh-Biologika-2023-23 Insulin Glargine (Potency: 100 U/Ml)
Deadline - Aug 31, 2025
MT reference number - 69493864
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 69493864
Document Type - Tender Notices
Description - The health insurers involved are pursuing the goal of concluding discount agreements for the active substance insulin glargine (potency: 100 U/ml) with all suitable pharmaceutical companies in accordance with Section 130a (8) SGB V. The contract is c oncluded as part of the Open House Biologicals process of the health insurance companies involved: Individual negotiations on the content of the contract are not conducted, uniform conditions apply. The cash registers involved do not guarantee individual contractual partners any exclusivity. The contract period is a maximum of 24 months starting on September 1st, 2023. The contract ends on August 31, 2025 at the latest, regardless of the date of
Mt Ref Id - 69493864
Deadline - Aug 31, 2025
Similar Tenders :
Healthcare and Medicine